Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hanall Biopharma Company

Hanall Biopharma Company
1973 FOUNDED
PUBLIC STATUS
301-400 EMPLOYEES
009420 STOCK SYMBOL
3 INVESTMENTS
$18.85 SHARE PRICE (As of Friday Closing)
Description

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • 6th Fl., I-Space Building, 11-10
  • Sincheon-Dong
  • Songpa-Gu, 138-922
  • South Korea

+49 08222 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hanall Biopharma Company’s full profile, request a free trial.

Hanall Biopharma Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$11.65 - $33.97 $965M $17.67 $0.32 832K 51.2M

Hanall Biopharma Company Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
31-Dec-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Enterprise Value 1,521,868 1,521,868 1,576,713 1,107,970
Revenue 93,006 93,006 83,558 74,279
EBITDA 15,473 15,473 3,698 3,431
Net Income 16,444 16,444 3,003 5,126
Total Assets 165,221 165,221 145,134 157,865
Total Debt 491 491 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hanall Biopharma Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Hanall Biopharma Company‘s full profile, request access.

Request full access to PitchBook

Hanall Biopharma Company Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 19-Jul-2019 00000 00000 00 000.00 Biotechnology
000000000 05-Feb-2016 00000 00000 00 00.00 Biotechnology 0000-000 000
ImmunoMet 01-Aug-2015 Seed Round 000 Biotechnology 0000-000 000
To view this company’s complete investment and acquisition history, request access »

Hanall Biopharma Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Hanall Biopharma Company‘s full profile, request access.

Request full access to PitchBook

Hanall Biopharma Company Executive Team (3)

Name Title Board
Seat
Contact
Info
Sung-Yon Lim Director, Finance Planning Division
SeungKook Park Ph.D Executive Vice President & Head, Research

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

Hanall Biopharma Company Board Members (1)

Name Representing Role Since Contact
Info
00000000 000 Hanall Biopharma Company Founder & Chairman 000 0000